Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70


Both the intratumoral immune and microbial microenvironment are linked to recurrence in human colon cancer: results from a prospective, multicenter nodal ultrastaging trial.

Noguti J, Chan AA, Bandera B, Brislawn CJ, Protic M, Sim MS, Jansson JK, Bilchik AJ, Lee DJ.

Oncotarget. 2018 May 4;9(34):23564-23576. doi: 10.18632/oncotarget.25276. eCollection 2018 May 4.


Low intratumoral regulatory T cells and high peritumoral CD8(+) T cells relate to long-term survival in patients with pancreatic ductal adenocarcinoma after pancreatectomy.

Liu L, Zhao G, Wu W, Rong Y, Jin D, Wang D, Lou W, Qin X.

Cancer Immunol Immunother. 2016 Jan;65(1):73-82. doi: 10.1007/s00262-015-1775-4. Epub 2015 Dec 8.


Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer.

Matsumoto H, Thike AA, Li H, Yeong J, Koo SL, Dent RA, Tan PH, Iqbal J.

Breast Cancer Res Treat. 2016 Apr;156(2):237-47. doi: 10.1007/s10549-016-3743-x. Epub 2016 Mar 9.


Peripheral Leukocytosis Is Inversely Correlated with Intratumoral CD8+ T-Cell Infiltration and Associated with Worse Outcome after Chemoradiotherapy in Anal Cancer.

Martin D, Rödel F, Winkelmann R, Balermpas P, Rödel C, Fokas E.

Front Immunol. 2017 Sep 29;8:1225. doi: 10.3389/fimmu.2017.01225. eCollection 2017.


Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.

Gabrielson A, Wu Y, Wang H, Jiang J, Kallakury B, Gatalica Z, Reddy S, Kleiner D, Fishbein T, Johnson L, Island E, Satoskar R, Banovac F, Jha R, Kachhela J, Feng P, Zhang T, Tesfaye A, Prins P, Loffredo C, Marshall J, Weiner L, Atkins M, He AR.

Cancer Immunol Res. 2016 May;4(5):419-30. doi: 10.1158/2326-6066.CIR-15-0110. Epub 2016 Mar 11.


Intratumoral CD8⁺ cytotoxic lymphocyte is a favorable prognostic marker in node-negative breast cancer.

Chen Z, Chen X, Zhou E, Chen G, Qian K, Wu X, Miao X, Tang Z.

PLoS One. 2014 Apr 17;9(4):e95475. doi: 10.1371/journal.pone.0095475. eCollection 2014.


Predictive and prognostic significance of CD8+ tumor-infiltrating lymphocytes in patients with luminal B/HER 2 negative breast cancer treated with neoadjuvant chemotherapy.

Al-Saleh K, Abd El-Aziz N, Ali A, Abozeed W, Abd El-Warith A, Ibraheem A, Ansari J, Al-Rikabi A, Husain S, Nabholtz JM.

Oncol Lett. 2017 Jul;14(1):337-344. doi: 10.3892/ol.2017.6144. Epub 2017 May 10.


Analysis of the tonsillar microbiome in young adults with sore throat reveals a high relative abundance of Fusobacterium necrophorum with low diversity.

Atkinson TP, Centor RM, Xiao L, Wang F, Cui X, Van Der Pol W, Morrow CD, Ratliff AE, Crabb DM, Totten AH, Estrada CA, Faircloth MB, Waites KB.

PLoS One. 2018 Jan 19;13(1):e0189423. doi: 10.1371/journal.pone.0189423. eCollection 2018.


The Microbiome in Lung Cancer Tissue and Recurrence-Free Survival.

Peters BA, Hayes RB, Goparaju C, Reid C, Pass HI, Ahn J.

Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):731-740. doi: 10.1158/1055-9965.EPI-18-0966. Epub 2019 Feb 7.


Comparison of 627 patients with right- and left-sided colon cancer in China: Differences in clinicopathology, recurrence, and survival.

Qin Q, Yang L, Sun YK, Ying JM, Song Y, Zhang W, Wang JW, Zhou AP.

Chronic Dis Transl Med. 2017 Mar 13;3(1):51-59. doi: 10.1016/j.cdtm.2017.02.004. eCollection 2017 Mar 25.


Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW, Tang ZY.

J Clin Oncol. 2007 Jun 20;25(18):2586-93.


Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection.

Chen KJ, Zhou L, Xie HY, Ahmed TE, Feng XW, Zheng SS.

Med Oncol. 2012 Sep;29(3):1817-26. doi: 10.1007/s12032-011-0006-x. Epub 2011 Jun 16.


Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma.

Jensen HK, Donskov F, Marcussen N, Nordsmark M, Lundbeck F, von der Maase H.

J Clin Oncol. 2009 Oct 1;27(28):4709-17. doi: 10.1200/JCO.2008.18.9498. Epub 2009 Aug 31.


Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prospective trials.

Bilchik A, Nissan A, Wainberg Z, Shen P, McCarter M, Protic M, Howard R, Elashoff D, Tyler J, Peoples GE, Stojadinovic A.

Ann Surg. 2010 Sep;252(3):467-74; discussion 474-6. doi: 10.1097/SLA.0b013e3181f19767.


Increase of programmed death-1-expressing intratumoral CD8 T cells predicts a poor prognosis for nasopharyngeal carcinoma.

Hsu MC, Hsiao JR, Chang KC, Wu YH, Su IJ, Jin YT, Chang Y.

Mod Pathol. 2010 Oct;23(10):1393-403. doi: 10.1038/modpathol.2010.130. Epub 2010 Jul 23.


Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer.

Yan X, Jiao SC, Zhang GQ, Guan Y, Wang JL.

Cancer Gene Ther. 2017 Feb;24(2):57-63. doi: 10.1038/cgt.2016.40. Epub 2017 Jan 13.


Associations between cigarette smoking status and colon cancer prognosis among participants in North Central Cancer Treatment Group Phase III Trial N0147.

Phipps AI, Shi Q, Newcomb PA, Nelson GD, Sargent DJ, Alberts SR, Limburg PJ.

J Clin Oncol. 2013 Jun 1;31(16):2016-23. doi: 10.1200/JCO.2012.46.2457. Epub 2013 Apr 1.


Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.

Miyashita M, Sasano H, Tamaki K, Hirakawa H, Takahashi Y, Nakagawa S, Watanabe G, Tada H, Suzuki A, Ohuchi N, Ishida T.

Breast Cancer Res. 2015 Sep 4;17:124. doi: 10.1186/s13058-015-0632-x.


Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance).

Singh PP, Shi Q, Foster NR, Grothey A, Nair SG, Chan E, Shields AF, Goldberg RM, Gill S, Kahlenberg MS, Sinicrope FA, Sargent DJ, Alberts SR.

Oncologist. 2016 Dec;21(12):1509-1521. Epub 2016 Nov 23.

Supplemental Content

Support Center